---
schema_version: "secwatch.filing_event.v1"
accession: "0001274737-21-000085"
form_type: "8-K"
ticker: "XGN"
cik: "0001274737"
company_name: "EXAGEN INC."
filed_at: "2021-07-30T23:59:59+00:00"
generated_at: "2026-06-30T00:16:30.766585+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Exagen appoints Ana Hooker to board of directors; she is SVP Operations at Exact Sciences

## Summary
- Board increased from 8 to 9 members; appointment effective July 29, 2021.
- Hooker receives option to purchase 15,000 shares, vesting over 3 years monthly, plus cash compensation per non-employee director plan.
- Hooker is SVP Operations at Exact Sciences since 2015; previously 15 years at ARUP Laboratories.
- Board determined Hooker is independent under Nasdaq listing standards.

## SEC filing metadata
- accession: 0001274737-21-000085
- form_type: 8-K
- ticker: XGN
- cik: 0001274737
- company_name: EXAGEN INC.
- filed_at: 2021-07-30T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000085/0001274737-21-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000085/xgnxdirectorappointment7x2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001274737-21-000085
- JSON: https://secwatch.observer/filing/0001274737-21-000085.json
- Plain text: https://secwatch.observer/filing/0001274737-21-000085.txt

## Key facts
- Executive change
  Ana Hooker was appointed as Director at EXAGEN INC..
  - Action: appointed
  - Role: Director
  source text: the Board approved an increase in its authorized size from eight members to nine members and appointed Ana Hooker to fill the vacancy created by such increase and serve as a Class II director, with an initial term expiring at the Company's 2024 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000085/0001274737-21-000085-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.